Risk factor
Very vulnerable to price shocks
Profitability factor
Favourable analyst view
About
Al Hammadi Company For Development and Investment establishes, maintains, manages, and operates hospitals and medical centers in the Kingdom of Saudi Arabia. The company operates through Medical Services and Pharmaceuticals Products segments. It is also involved in the wholesale and retail trading of medical equipment, pharmaceutical and cosmetic products, and food and beverages; and the...
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. Specifically, the stock is 'cheap' on P/E, neutral on EV/EBITD
Target Price
The average target price of 4007.SR is 39 and suggests 42% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incre
Buy
Sell